Stock 6118 AUSTAR LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Austar Lifesciences Limited

Equities

6118

KYG0632L1023

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
0.82 HKD -7.87% Intraday chart for Austar Lifesciences Limited -18.00% -47.44%
Mar. 26 Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 22 Austar Lifesciences to Swing to Loss; Shares Drop MT

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 1,212 2,548 2,368 2,627 6,298 914.5
Enterprise Value (EV) 1 923 2,377 2,235 2,526 6,234 1,103
P/E ratio -21.5 x 23,894 x 293 x 85.4 x 22.8 x 10.5 x
Yield - - - - - -
Capitalization / Revenue 2.22 x 3.12 x 2.26 x 2.03 x 3.13 x 0.41 x
EV / Revenue 1.69 x 2.91 x 2.13 x 1.95 x 3.09 x 0.49 x
EV / EBITDA -15.3 x -1,007 x 114 x 58.5 x 47.7 x 10.4 x
EV / FCF 42.8 x -21.6 x 97 x -79.8 x -26.3 x -5.51 x
FCF Yield 2.33% -4.63% 1.03% -1.25% -3.81% -18.2%
Price to Book 2.53 x 5.3 x 4.79 x 5.07 x 8.01 x 1.02 x
Nbr of stocks (in thousands) 512,582 512,582 512,582 512,582 512,582 512,582
Reference price 2 2.365 4.970 4.620 5.126 12.29 1.784
Announcement Date 4/19/18 4/18/19 4/23/20 4/21/21 4/25/22 4/24/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 546.9 816.6 1,049 1,296 2,015 2,229
EBITDA 1 -60.21 -2.361 19.54 43.18 130.6 106.1
EBIT 1 -68.12 -9.934 7.791 29.73 117 90.39
Operating Margin -12.45% -1.22% 0.74% 2.29% 5.8% 4.06%
Earnings before Tax (EBT) 1 -58.42 3.498 12.21 41.49 319.2 86.48
Net income 1 -54.08 0.107 8.091 33.1 277.3 87.46
Net margin -9.89% 0.01% 0.77% 2.55% 13.76% 3.92%
EPS 2 -0.1100 0.000208 0.0158 0.0600 0.5400 0.1700
Free Cash Flow 1 21.55 -110 23.06 -31.65 -237.3 -200.2
FCF margin 3.94% -13.47% 2.2% -2.44% -11.78% -8.98%
FCF Conversion (EBITDA) - - 117.99% - - -
FCF Conversion (Net income) - - 284.95% - - -
Dividend per Share - - - - - -
Announcement Date 4/19/18 4/18/19 4/23/20 4/21/21 4/25/22 4/24/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - 188
Net Cash position 1 290 171 133 102 64.5 -
Leverage (Debt/EBITDA) - - - - - 1.776 x
Free Cash Flow 1 21.5 -110 23.1 -31.7 -237 -200
ROE (net income / shareholders' equity) -10.6% 0.02% 1.51% 6.15% 41.5% 8.1%
ROA (Net income/ Total Assets) -4.74% -0.64% 0.43% 1.46% 4.27% 2.55%
Assets 1 1,141 -16.83 1,866 2,274 6,493 3,432
Book Value Per Share 2 0.9300 0.9400 0.9600 1.010 1.530 1.750
Cash Flow per Share 2 0.6000 0.3800 0.3700 0.3500 0.3900 0.2600
Capex 1 9.1 5.19 13.7 26.5 101 117
Capex / Sales 1.66% 0.64% 1.31% 2.05% 4.99% 5.26%
Announcement Date 4/19/18 4/18/19 4/23/20 4/21/21 4/25/22 4/24/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
AUSTAR LIFESCIENCES LIMITED Stock Austar Lifesciences Limited
-47.44% 53.69M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 6118 Stock
  4. Financials Austar Lifesciences Limited